Biorefining company Green Plains (NASDAQ:GPRE) will be reporting earnings this Thursday morning. Here’s what you need to know.
Green Plains missed analysts’ revenue expectations last quarter, reporting revenues of $445.8 million, down 25.9% year on year. It was a very strong quarter for the company, with a beat of analysts’ EPS estimates and an impressive beat of analysts’ EBITDA estimates.
Is Green Plains a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Green Plains’s revenue to grow 1.3% year on year, a reversal from the 10.7% decrease it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings.
Looking at Green Plains’s peers in the mixed or offshore upstream e&p segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Vitesse Energy delivered year-on-year revenue growth of 11.3%, beating analysts’ expectations by 8.2%, and Kosmos Energy reported revenues up 54.6%, topping estimates by 28.4%. Vitesse Energy’s stock price was unchanged after the resultswhile Kosmos Energy was down 8.9%.
Read our full analysis of Vitesse Energy’s results here and Kosmos Energy’s results here.
There has been positive sentiment among investors in the mixed or offshore upstream e&p segment, with share prices up 6.7% on average over the last month. Green Plains is up 8% during the same time and is heading into earnings with an average analyst price target of $17.71 (compared to the current share price of $17.02).
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.